Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Recurrent Disease
100%
Crohn's Disease
86%
Patient with Crohn's Disease
50%
Risk Stratification
34%
Cohort Analysis
30%
Immunomodulating Agent
25%
Diseases
24%
Bowel Resection
20%
Postoperative Management
19%
Hazard Ratio
15%
Tumor Necrosis Factor
14%
Cohort Effect
14%
Retreatment
14%
Prospective Study
14%
Monotherapy
14%
Inflammatory Bowel Disease
12%
Proportional Hazards Model
10%
Combination Therapy
9%
Biological Product
8%
Surgical Margin
8%
4-Aminosalicylic Acid
7%
Recurrence Risk
6%
Cumulative Incidence
6%
TNF Inhibitor
5%
Pharmacology, Toxicology and Pharmaceutical Science
Crohn's Disease
74%
Recurrent Disease
68%
Tumor Necrosis Factor
29%
Diseases
22%
Immunomodulating Agent
20%
Prospective Study
14%
Monotherapy
14%
Mercaptopurine
14%
Tumor Necrosis Factor Inhibitor
11%
Recurrence Risk
7%
Biological Product
7%
Combination Therapy
7%
Aminosalicylic Acid
5%